Homeostatic inflammation in innate immunity

Current Opinion in Immunology

Volumn 30, Issue 1, 2014, Pages 85-90

  Miyake, Kensuke ^a   Kaisho, Tsuneyasu ^b,c,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b Institute of Physical and Chemical Research   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DEOXYRIBONUCLEASE; MAMMALIAN TARGET OF RAPAMYCIN; NUCLEIC ACID; PROTEIN MD 2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; DENDRITIC CELL; ENDOLYSOSOME; HOMEOSTASIS; HUMAN; IMMUNE COMPLEX DEPOSITION; INFLAMMATION; INNATE IMMUNITY; INTERFERON INDUCTION; INTERFERON PRODUCTION; LYSOSOME; MACROPHAGE; NONHUMAN; PSORIASIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ANTIGEN RECOGNITION; BACTERIAL IMMUNITY; IMMUNE HOMEOSTASIS; IMMUNOREGULATION; INFLAMMATORY DISEASE; INTESTINE ISCHEMIA; PATHOGENESIS; PERITONITIS; SIGNAL TRANSDUCTION; ANIMAL; BONE MARROW CELL; IMMUNOLOGY;

ANIMALS; DENDRITIC CELLS; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MYELOID CELLS;

EID: 84907758643     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.08.003     Document Type: Review

References (39)

1. Marshak-Rothstein A., Rifkin I.R. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 2007, 25:419-441.
2. Barton G.M., Kagan J.C. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol 2009, 9:535-542.
3. Gavin A.L., Hoebe K., Duong B., Ota T., Martin C., Beutler B., Nemazee D. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 2006, 314:1936-1938.
4. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001, 2:947-950.
5. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., Du X., Hoebe K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006, 24:353-389.
6. Kaisho T., Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006, 117(979-987). quiz 988.
7. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373-384.
8. Ohto U., Fukase K., Miyake K., Satow Y. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 2007, 316:1632-1634.
9. Wong S.W., Kwon M.J., Choi A.M., Kim H.P., Nakahira K., Hwang D.H. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009, 284:27384-27392.
10. Suganami T., Tanimoto-Koyama K., Nishida J., Itoh M., Yuan X., Mizuarai S., Kotani H., Yamaoka S., Miyake K., Aoe S., et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007, 27:84-91.
11. West X.Z., Malinin N.L., Merkulova A.A., Tischenko M., Kerr B.A., Borden E.C., Podrez E.A., Salomon R.G., Byzova T.V. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 2010, 467:972-976.
12. Settembre C., De Cegli R., Mansueto G., Saha P.K., Vetrini F., Visvikis O., Huynh T., Carissimo A., Palmer D., Klisch T.J., et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat Cell Biol 2013, 15:647-658.
13. Tanimura N., Saitoh S., Matsumoto F., Akashi-Takamura S., Miyake K. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem Biophys Res Commun 2008, 368:94-99.
14. Kagan J.C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 2008, 9:361-368.
15. Bernard J.J., Cowing-Zitron C., Nakatsuji T., Muehleisen B., Muto J., Borkowski A.W., Martinez L., Greidinger E.L., Yu B.D., Gallo R.L. Ultraviolet radiation damages self noncoding RNA and is detected by TLR3. Nat Med 2012.
16. Cavassani K.A., Ishii M., Wen H., Schaller M.A., Lincoln P.M., Lukacs N.W., Hogaboam C.M., Kunkel S.L. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008, 205:2609-2621.
17. Takemura N., Kawasaki T., Kunisawa J., Sato S., Lamichhane A., Kobiyama K., Aoshi T., Ito J., Mizuguchi K., Karuppuchamy T., et al. Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome. Nat Commun 2014, 5:3492.
18. Sasai M., Linehan M.M., Iwasaki A. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 2010, 329:1530-1534.
19. Cao W., Manicassamy S., Tang H., Kasturi S.P., Pirani A., Murthy N., Pulendran B. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol 2008, 9:1157-1164.
20. Colina R., Costa-Mattioli M., Dowling R.J., Jaramillo M., Tai L.H., Breitbach C.J., Martineau Y., Larsson O., Rong L., Svitkin Y.V., et al. Translational control of the innate immune response through IRF-7. Nature 2008, 452:323-328.
21. Weinstein S.L., Finn A.J., Davé S.H., Meng F., Lowell C.A., Sanghera J.S., DeFranco A.L. Phosphatidylinositol 3-kinase and mTOR mediate lipopolysaccharide-stimulated nitric oxide production in macrophages via interferon-beta. J Leuk Biol 2000, 67:405-414.
22. Efeyan A., Zoncu R., Sabatini D.M. Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med 2012, 18:524-533.
23. Yasutomo K., Horiuchi T., Kagami S., Tsukamoto H., Hashimura C., Urushihara M., Kuroda Y. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001, 28:313-314.
24. Napirei M., Karsunky H., Zevnik B., Stephan H., Mannherz H.G., Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 2000, 25:177-181.
25. Kawane K., Ohtani M., Miwa K., Kizawa T., Kanbara Y., Yoshioka Y., Yoshikawa H., Nagata S. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 2006, 443:998-1002.
26. Gall A., Treuting P., Elkon K.B., Loo Y.M., Gale M., Barber G.N., Stetson D.B. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 2012, 36:120-131.
27. Fukui R., Saitoh S., Matsumoto F., Kozuka-Hata H., Oyama M., Tabeta K., Beutler B., Miyake K. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J Exp Med 2009, 206:1339-1350.
28. Fukui R., Saitoh S., Kanno A., Onji M., Shibata T., Ito A., Matsumoto M., Akira S., Yoshida N., Miyake K. Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Immunity 2011, 35:69-81.
29. Okuma A., Hoshino K., Ohba T., Fukushi S., Aiba S., Akira S., Ono M., Kaisho T., Muta T. Enhanced apoptosis by disruption of the STAT3-IκB-ζ signaling pathway in epithelial cells induces Sjögren's syndrome-like autoimmune disease. Immunity 2013, 38:450-460.
30. Bar-On L., Jung S. Defining dendritic cells by conditional and constitutive cell ablation. Immunol Rev 2010, 234:76-89.
31. Kim S., Kaiser V., Beier E., Bechheim M., Guenthner-Biller M., Ablasser A., Berger M., Endres S., Hartmann G., Hornung V. Self-priming determines high type I IFN production by plasmacytoid dendritic cells. Eur J Immunol 2014, 44:807-818.
32. Gregorio J., Meller S., Conrad C., Di Nardo A., Homey B., Lauerma A., Arai N., Gallo R.L., Digiovanni J., Gilliet M. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J Exp Med 2010, 207:2921-2930.
33. Shortman K., Heath W.R. The CD8+ dendritic cell subset. Immunol Rev 2010, 234:18-31.
34. Murphy K.M. Transcriptional control of dendritic cell development. Adv Immunol 2013, 120:239-267.
35. Yamazaki C., Sugiyama M., Ohta T., Hemmi H., Hamada E., Sasaki I., Fukuda Y., Yano T., Nobuoka M., Hirashima T., et al. Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1. J Immunol 2013, 190:6071-6082.
36. Kawashima T., Kosaka A., Yan H., Guo Z., Uchiyama R., Fukui R., Kaneko D., Kumagai Y., You D.J., Carreras J., et al. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-β. Immunity 2013, 38:1187-1197.
37. Pearce E.L., Poffenberger M.C., Chang C.H., Jones R.G. Fueling immunity: insights into metabolism and lymphocyte function. Science 2013, 342:1242454.
38. Maciolek J.A., Alex Pasternak J., Wilson H.L. Metabolism of activated T lymphocytes. Curr Opin Immunol 2014, 27C:60-74.
39. Everts B., Amiel E., Huang S.C., Smith A.M., Chang C.H., Lam W.Y., Redmann V., Freitas T.C., Blagih J., van der Windt G.J., et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKe{open} supports the anabolic demands of dendritic cell activation. Nat Immunol 2014, 15:323-332.